Cebranopadol reduced pain intensity in patients following abdominoplasty surgery in the ALLEVIATE-1 clinical trial.

You don’t have to have a run in with the law to get help. The province has introduced on-demand access to opioid agonist ...

and willingness to continue opioid therapy. A literature search identified more than a dozen published reports on the use of pure opioid antagonists (naloxone, naltrexone, methylnaltrexone ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

A partial opioid agonist, buprenorphine occupies opioid ... and is typically available in conjunction with counseling and behavioral therapy. Why does my body shake? Stopping alcohol consumption ...

Oklahoma lawmakers will consider several bills during the 2025 legislative session that could change state mental health and ...

Ben Hargreaves finds that a new line of attack could be the development of more effective non-opioid painkillers, with one potential therapy moving ... attaching to opioid receptors on nerve ...

Insights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

Study of 2.4 million participants reveals potential advantages for cardiometabolic and psychiatric conditions alongside increased risks of gastrointestinal and musculoskeletal issues Study ...

The medicines may not only suppress appetite but also help curb alcoholism and other addictions. Read more at straitstimes.com.